Effect of C-peptide on diabetic neuropathy in patients with type 1 diabetes (Q37113466)

18 August 2017

6 references

14 March 2019

24 March 2019

25 April 2019

17 November 2019

20 November 2019

17 July 2021

Effect of C-peptide on diabetic neuropathy in patients with type 1 diabetes (English)

1 reference

18 August 2017

0 references

5 references

14 March 2019

24 March 2019

25 April 2019

17 November 2019

20 November 2019

1 reference

17 November 2019

1 reference

20 November 2019

1 reference

17 July 2021

Karin Ekberg

1

1 reference

PMCID

2266809

18 August 2017

Bo-Lennart Johansson

series ordinal

2

1 reference

PMCID

2266809

18 August 2017

language of work or name

1 reference

1 January 2008

1 reference

Experimental Diabetes Research

18 August 2017

7 references

18 August 2017

14 March 2019

24 March 2019

25 April 2019

17 November 2019

20 November 2019

17 July 2021

2008

1 reference

18 August 2017

457912

1 reference

Creative Commons Attribution 3.0 Unported

18 August 2017

6 references

14 March 2019

24 March 2019

25 April 2019

17 November 2019

20 November 2019

on focus list of Wikimedia project

17 July 2021

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

C-peptide is a bioactive peptide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

Treatment of diabetic polyneuropathy: Update 2006.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

The pathobiology of diabetic complications: a unifying mechanism

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

Diabetic neuropathies: a statement by the American Diabetes Association

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

New insights into the metabolic and molecular basis for diabetic neuropathy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

Diabetic neuropathy--a continuing enigma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

Specific binding of proinsulin C-peptide to human cell membranes

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

Prevention of vascular and neural dysfunction in diabetic rats by C-peptide.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

Complications: neuropathy, pathogenetic considerations

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

New approaches for treatment in diabetes: aldose reductase inhibitors

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term type 1 (insulin-dependent) diabetes mellitus

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

Residual C-peptide excretion is associated with a better long-term glycemic control and slower progress of retinopathy in type I (insulin-dependent) diabetes mellitus

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

Aldose reductase inhibition by AS-3201 in sural nerve from patients with diabetic sensorimotor polyneuropathy

27 June 2018

1 reference

https://api.crossref.org/works/10.1155%2F2008%2F457912

Effects of proinsulin C-peptide in experimental diabetic neuropathy: vascular actions and modulation by nitric oxide synthase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2008%2F457912

The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2008%2F457912

Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2008%2F457912

C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2008%2F457912

Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2008%2F457912

Proinsulin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2008%2F457912

Progressive centripetal degeneration of axons in small fibre diabetic polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2008%2F457912

Diabetic neuropathy: mechanisms and future treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2008%2F457912

Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2008%2F457912

Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266809

Report and recommendations of the San Antonio conference on diabetic neuropathy

3 September 2018

1 reference

12 December 2020

Higher post-absorptive C-peptide levels in Type 1 diabetic patients without renal complications

1 reference

12 December 2020

Showing neuropathy is related to increased mortality in diabetic patients - a survival analysis using an accelerated failure time model

1 reference

12 December 2020

Amelioration of sensory nerve dysfunction by C-Peptide in patients with type 1 diabetes

1 reference

12 December 2020

Reversible and irreversible nodal dysfunction in diabetic neuropathy

1 reference

12 December 2020

The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus

1 reference

12 December 2020

Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial

1 reference

12 December 2020

C-peptide improves autonomic nerve function in IDDM patients

1 reference

12 December 2020

Nodal Na(+)-channel displacement is associated with nerve-conduction slowing in the chronically diabetic BB/W rat: prevention by aldose reductase inhibition

1 reference

12 December 2020

Worldwide pharmacovigilance systems and tolrestat withdrawal

1 reference

12 December 2020

Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4

1 reference

12 December 2020

C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

1 reference

12 December 2020

Identifiers

DOI

10.1155/2008/457912

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

PMCID

2266809